250 P. Westermark 50. Willén R, Willén H, Lindstedt E, Ekelund L. Localized primary amyloidosis of the ureter. Scand J Urol Nephrol. 1983;17:385–9. 51. Da Costa P, Corrin B. Amyloidosis localized to the lower respiratory tract: probably immunoamyloid nature of the tracheobronchial and nodular pulmonary forms. Histopathol- ogy. 1985;9:703–10. 52. Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90:827–31. 53. Grünewald K, Sepp N, Weyrer K, Lhotta K, Feichtinger H, Konwalinka G, et al. Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutaneous amyloidosis. J Invest Dermatol. 1991;97:693–6. 54. Mukhopadhyay S, Damron TA, Valente AL. Recurrent amy- loidoma of soft tissue with exuberant giant cell reaction. Arch Pathol Lab Med. 2003;127:1609–11. 55. Makheshwari AV, Muro-Cacho CA, Kransdorf MJ, Temple HT. Soft-tissue amyloidoma of the extremities: a case report and review of literature. Skeletal Radiol. 2009; 38:287–92. 56. Shirahama T, Cohen AS. Intralysosomal formation of amyloid ﬁbrils. Am J Pathol. 1975;81:101–16. 57. Helming L, Gordon S. The molecular basis of macrophage fusion. Immunobiology. 2008;212:785–93. 58. Enelow RI, Sullivan GW, Carper HT, Mandell GL. Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferon-gamma: comparison with other stimulating factors. Am J Respir Cell Mol Biol. 1992;6:57–62. 59. Fais S, Burgio VL, Silvestri M, Capobianchi MR, Pacchiarotti A, Pallone F. Multinuclear giant cell generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophage fusion and multinucleated giant cell formation. Lab Invest. 1994;71:737–44. 60. McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Dif- ferential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol. 1995;147:1487–99. 61. Dugast C, Gaudin A, Toujas L. Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4. J Leukoc Biol. 1997;61:517–21. 62. Jenney CR, DeFife KM, Colton E, Anderson JM. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-mod- iﬁed surfaces in vitro. J Biomed Mater Res. 1998;41:171–84. 63. Helming L, Winter J, Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci. 2009;122:453–9. 64. McNally AK, Anderson JM. Foreign body-type multinucle- ated giant cells induced by interleukin-4 express select lym- phocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells. Exp Mol Pathol. 2011;91:673–81. 65. Ikeda T, Ikeda K, Sasaki K, Kawakami K, Hatake K, Kaji Y, et al. IL-13 as well as IL-4 induces monocytes/macro- phages and a monoblastic cell line (UG3) to differentiate into multinucleated giant cells in the presence of M-CSF. Biochem Biophys Res Commun. 1998;253:265–72. 66. Zhu J, Qiu Y, Valobra M, Qiu S, Majumdar S, Matin D, et al. Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1125–33. 67. Rodriguez A, MacEwan SR, Meyerson H, Kirk JT, Anderson JM. The foreign body reaction in T-cell-deﬁcient mice. J Biomed Mater Res. 2009;90A:106–13. 68. Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21:421–30. 69. Kanoh T, Suzuki K, Kawaguchi S. Multifocal nodular AL amyloidosis in primary Sjögren’s syndrome. Rinsho Ketsueki. 1998;39:1157–62; Japanese. 70. Götz J, Eckert A, Matamales M, Ittner LM, Liu X. Modes of Ab toxicity in Alzheimer’s disease. Cell Mol Life Sci. 2011;68: 3359–75. 71. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid and diabetes mellitus. Physiol Rev. 2011;91:795–826. 72. Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, et al. Serum N-terminal and pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation. 2003;107:2440–5. 73. Westermark GT, Sletten K, Westermark P. Alkali- degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid ﬁbril proteins. Scand J Immunol. 2009;70:535–40.